For a two-step Tuberculin Purified Protein Derivative (PPD) test, is the second PPD placement administered 7 days from the placement or the reading of the first test?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 30, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Two-Step PPD Test Timing

The second PPD should be placed 1-3 weeks after the reading of the first test (which occurs at 48-72 hours post-placement), meaning the second placement occurs approximately 1-3 weeks after the first test was read, not from the initial placement. 1, 2

Timing Algorithm for Two-Step Testing

Standard Two-Step Protocol

  • Day 0: Place first PPD test 3
  • Day 2-3 (48-72 hours): Read first PPD test 3
  • Day 9-24 (1-3 weeks after first reading): Place second PPD test if first test is negative 1, 2
  • Day 11-26 (48-72 hours after second placement): Read second PPD test 1, 2

Critical Timing Considerations

The 1-3 week interval is measured from the first test reading, not placement, because:

  • The immunologic response needs time to develop after the first tuberculin exposure 1
  • Placing the second test too soon can interfere with the immunological response and lead to inaccurate results 1
  • This interval allows detection of the "booster phenomenon" where waned TB immunity is restored by the initial PPD 1, 2

Clinical Context for Two-Step Testing

When Two-Step Testing Is Required

  • Healthcare workers: All newly employed HCWs with initial negative PPD and no documented negative test within preceding 12 months 1, 2
  • Serial testing populations: Healthcare facilities, correctional institutions, nursing homes where periodic TB screening occurs 1, 2
  • High prior exposure risk: Populations with high rates of previous TB exposure or BCG vaccination 1

Purpose of Two-Step Method

The two-step process prevents misinterpretation of boosted reactions as new infections during subsequent serial testing 1, 2. Without this baseline establishment, a boosted reaction on future annual testing might be incorrectly classified as a conversion, triggering unnecessary contact investigations and preventive therapy 1.

Common Pitfalls to Avoid

  • Timing error: Measuring the 1-3 week interval from placement rather than reading leads to improper timing 1, 2
  • Reading window: Tests must be read at 48-72 hours; readings outside this window reduce accuracy 3, 4
  • Patient self-reading: Never rely on patient self-reading of results—this is highly inaccurate 5
  • Measuring erythema: Only measure induration (hardened area), not redness 3, 1

Special Populations

The booster phenomenon is particularly common in:

  • Older adults 1
  • Individuals with previous BCG vaccination 1, 6
  • Foreign-born persons from high TB prevalence countries 1
  • Those exposed to nontuberculous mycobacteria 1

References

Guideline

PPD Screening for Tuberculosis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Timing of Tuberculin Skin Testing

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Reading the tuberculin skin test. Who, when, and how?

Archives of internal medicine, 1988

Related Questions

When can the second Tuberculin (TB) skin test be placed after reading the first in a 2-step TB skin test for an adult or adolescent with no known history of TB infection or recent exposure?
How many hours are required to read the results of a Tuberculin Skin Test (TST)?
When can the second Tuberculin (TB) skin test be placed in a 2-step Tuberculin (TB) test?
What is the proper procedure for administering a Mantoux test (Tuberculin Skin Test)?
When is the second Tuberculin (TB) skin test placed following the first Tuberculin (TB) skin test?
What are the implications and management strategies for a patient with hyperfolatemia (>23.70 ng/mL) and normal vitamin B12 levels (333 pg/mL)?
What is the preferred initial treatment for a patient with cough due to asthma or COPD, albuterol nebs or Duonebs?
What antihypertensive medication has the least reported side effects in a general adult population with hypertension and no significant comorbidities?
What is the optimal Lantus (insulin glargine) dosing strategy for a 95kg patient with diabetes?
What are the differential diagnoses for a 25-year-old male with a 6-month history of hyperhidrosis (excessive sweating) of hands, feet, and groin, accompanied by dizziness, and who has a past medical history of presumed seizure and migraine, currently taking Keppra (levetiracetam), Depakote (valproate), and Sumatriptan (sumatriptan)?
Is it safe to use ipratropium (ipratropium bromide) nebulizer treatments in a 13-year-old patient with respiratory symptoms, possibly asthma or chronic obstructive pulmonary disease (COPD)?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.